OAC extends third merger extension deadline to May 25, 2027
Oaktree Acquisition Corp. III Life Sciences has approved an amendment to its charter to extend the window for a business combination to the later of November 25, 2026, or May 25, 2027, with a termination date in May. The company continues to focus on identifying a strategic target for merger.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed